Search Results - "Bisegna, R"

  • Showing 1 - 14 results of 14
Refine Results
  1. 1

    Evaluation of widely used models for predicting BRCA1 and BRCA2 mutations by Marroni, F, Aretini, P, D’Andrea, E, Caligo, M A, Cortesi, L, Viel, A, Ricevuto, E, Montagna, M, Cipollini, G, Ferrari, S, Santarosa, M, Bisegna, R, Bailey-Wilson, J E, Bevilacqua, G, Parmigiani, G, Presciuttini, S

    Published in Journal of medical genetics (01-04-2004)
    “…[...]all models except the Myriad Tables overestimated mutation probabilities in the highest risk group Overall, two of the Mendelian models (Brcapro and a…”
    Get full text
    Journal Article
  2. 2

    Reducing breast cancer incidence in familial breast cancer: overlooking the present panorama by Marchetti, P., Di Rocco, C.Z., Ricevuto, E., Bisegna, R., Cianci, G., Calista, F., Sidoni, T., Porzio, G., Ficorella, C.

    Published in Annals of oncology (01-01-2004)
    “…Familial breast cancer, whether associated or not with particular other breast cancer features (male, early onset, bilateral breast cancer), determines a wide…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Prognostic value of p53 molecular status in high-risk primary breast cancer by Marchetti, P., Cannita, K., Ricevuto, E., De Galitiis, F., Di Rocco, Z. C., Tessitore, A., Bisegna, R., Porzio, G., De Rubeis, G. P., Ventura, T., Martinotti, S., Ficorella, C.

    Published in Annals of oncology (01-05-2003)
    “…Background: Mutations in the p53 gene are the most common genetic alterations in human primary breast carcinoma and these mutations are often associated with…”
    Get full text
    Journal Article
  5. 5

    Immunologic Mechanisms Mediate Benefits of Lutenizing Hormone-Releasing Hormone (LH-RH) in High Risk Premenopausal Breast Cancer Patients (HR-Pre-BC) by Recchia, F., Recchia, F., Candeloro, G., Bisegna, R., Necozione, S., Recchia, C., Rea, S., Rea, S.

    Published in Cancer research (Chicago, Ill.) (15-12-2009)
    “…Abstract Background: Systematic reviews have found that LH-RH agonists are effective in the treatment of premenopausal women with early breast cancer. In an…”
    Get full text
    Journal Article
  6. 6

    Multicenter phase II study of sequential chemotherapy, radiotherapy, and immunotherapy in locally advanced pancreatic (Pa) and biliary tree (Bt) adenocarcinoma (ADK) by Recchia, F., Sica, G., Candeloro, G., Bisegna, R., Necozione, S., Bonfili, P., Tombolini, V., Rea, S.

    Published in Journal of clinical oncology (20-05-2009)
    “…Abstract only 3047 Background: The aim of this study was to evaluate the activity and toxicity of a multistep, sequential treatment including induction…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Immunotherapy in Patients with Less than Complete Response to Chemotherapy by RECCHIA, Francesco, CANDELORO, Giampiero, NECOZIONE, Stefano, BISEGNA, Roberta, BRATTA, Massimo, REA, Silvio

    Published in Anticancer research (01-02-2009)
    “…Background: Patients with metastatic solid tumors (MST) with less than a complete response to chemotherapy (L-CR), a depressed immune system and elevated serum…”
    Get full text
    Journal Article
  9. 9

    Maintenance Immunotherapy in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck by RECCHIA, Francesco, CANDELORO, Giampiero, DI STASO, Mario, NECOZIONE, Stefano, BISEGNA, Roberta, BRATTA, Massimo, TOMBOLINI, Vincenzo, REA, Silvio

    Published in Journal of immunotherapy (1997) (01-05-2008)
    “…The purpose of this study was to determine the efficacy and safety of a maintenance immunotherapy regimen administered to patients with recurrent/metastatic…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13

    Can analysis of the molecular status of the p53 gene contribute to improving the therapeutic strategy for breast carcinoma? by Ricevuto, E, Marchetti, P, Cannita, K, De Galitiis, F, Di Rocco, Z C, Tessitore, A, Martella, F, Bisegna, R, Porzio, G, Bafile, A, Vicentini, R, Resta, V, Mattucci, S, Ventura, T, Martinotti, S, de Rubeis, G P, Ficorella, C

    Published in Tumori (01-07-2003)
    “…The occurrence of mutations in the p53 tumor suppressor gene is a specific and recurring genetic event in solid tumors. P53 plays a pivotal role in multiple…”
    Get full text
    Journal Article
  14. 14